https://www.marketscreener.com/quote/stock/BIOMM-S-A-9970405/news/Biomm-S-A-Announces-Plans-to-Submit-Authorization-to-Conduct-Phase-3-Clinical-Studies-of-Leronlimab-33673177/?utm_source=telegram&utm_medium=social&utm_campaign=share